|
|
||||||||
American Journal of Clinical Nutrition, Vol 10, 512-515, Copyright © 1962 by The American Society for Clinical Nutrition, Inc.
1 From the Department of Environmental Medicine and Community Health, State University College of Medicine, Downstate Medical Center, Brooklyn, New York, and the Outpatient Service Division of the Brooklyn Hospital, Brooklyn, New York
Pyridoxine supplements were given to early prenatal patients, either in a capsule (one 20 mg. capsule daily), or as lozenges (6.67 mg., three times daily). The dental DMF rating was estimated at the beginning of the treatment period, and again, approximately six weeks postpartum.
The patients who received the pyridoxine supplement showed, on the average, a smaller increase in DMF rating than a comparison group of antenatal patients observed for the same period. The smallest increment in DMF rating was noted in the gravida receiving pyridoxine in the lozenge form.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |